The use of PDE5 inhibitors in the treatment of benign prostate hyperplasia and lower urinary tract symptoms: preclinical evidences

Sandner, Peter; Tinel, Hanna; Stelte-Ludwig, Beatrix; Bischoff, Erwin; Huetter, Joachim

doi:10.1186/1471-2210-7-S1-P48

BMC Pharmacology

Article metrics
Last updated: Thu, 18 Apr 2024 13:13:30 Z

The use of PDE5 inhibitors in the treatment of benign prostate hyperplasia and lower urinary tract symptoms: preclinical evidences

Access & Citations

2606

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.